1. Home
  2. XEL vs ONC Comparison

XEL vs ONC Comparison

Compare XEL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Energy Inc.

XEL

Xcel Energy Inc.

HOLD

Current Price

$77.44

Market Cap

49.9B

Sector

Utilities

ML Signal

HOLD

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$376.01

Market Cap

40.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XEL
ONC
Founded
1909
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9B
40.6B
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
XEL
ONC
Price
$77.44
$376.01
Analyst Decision
Buy
Strong Buy
Analyst Count
12
10
Target Price
$89.00
$385.10
AVG Volume (30 Days)
4.7M
356.8K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
140.43
EPS
1.82
0.31
Revenue
$11,537,000,000.00
$238,387,000.00
Revenue This Year
$9.77
$723.76
Revenue Next Year
$8.32
$15.04
P/E Ratio
$42.49
$1,199.94
Revenue Growth
N/A
22179.16
52 Week Low
$71.29
$253.95
52 Week High
$84.23
$385.22

Technical Indicators

Market Signals
Indicator
XEL
ONC
Relative Strength Index (RSI) 43.25 69.42
Support Level $77.00 $325.47
Resistance Level $82.05 $385.22
Average True Range (ATR) 1.39 7.78
MACD -0.07 1.00
Stochastic Oscillator 27.48 89.03

Price Performance

Historical Comparison
XEL
ONC

About XEL Xcel Energy Inc.

Xcel Energy manages utilities serving 3.9 million electric customers and 2.2 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan; Public Service Company of Colorado; and Southwestern Public Service Company, which serves customers in Texas and New Mexico. It is one of the largest renewable energy suppliers in the US, with more than half of its electricity sales coming from carbon-free energy.

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

Share on Social Networks: